Tudor Financial Inc. Sells 5,697 Shares of Amgen Inc. $AMGN

Tudor Financial Inc. reduced its stake in Amgen Inc. by 36.8% during the second quarter, selling 5,697 shares and retaining 9,784 shares valued at $3.54 million. Despite institutional ownership of 76.5%, analysts maintain a "Hold" consensus on Amgen with a target price of $380.43, even as some individual targets have been raised. Amgen reported strong Q2 earnings, surpassing expectations with $6.29 EPS and $10.05 billion in revenue, and declared a quarterly dividend of $2.52 per share.